3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
141
Lung Neoplasms
51
Pancreatic Neoplasms
30
Non-Squamous Non-Small Cell Lung Cancer
18
Neoplasms
15
Adenocarcinoma of Lung
14
Head and Neck Neoplasms
13
Glioblastoma
13
Gliosarcoma
12
Breast Neoplasms
11
Brain Neoplasms
11
Neoplasm Metastasis
9
Carcinoma, Hepatocellular
9
Adenocarcinoma, Bronchiolo-Alveolar
9
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Squamous Cell
7
Carcinoma, Renal Cell
7
Astrocytoma
6
Oligodendroglioma
5
Carcinoma
5
Urinary Bladder Neoplasms
4
Liver Neoplasms
4
Glioma
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Interventions
fludarabine phosphate
43
Whole-Body Irradiation
36
Mycophenolic Acid
36
Peripheral Blood Stem Cell Transplantation
31
Cyclophosphamide
31
Tacrolimus
28
Busulfan
22
Antilymphocyte Serum
21
Cyclosporine
19
fludarabine
17
ruxolitinib
16
Melphalan
16
Methotrexate
15
Cytarabine
12
thymoglobulin
9
Sirolimus
9
Etoposide
9
Granulocyte Colony-Stimulating Factor
8
Filgrastim
8
Cyclosporins
8
Radiotherapy
7
Cord Blood Stem Cell Transplantation
7
Rituximab
6
Alemtuzumab
6
merphos
5
Stem Cell Transplantation
5
Flow Cytometry
5
Azacitidine
5
sargramostim
4
ponatinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Myeloproliferative Disorders
×
Erlotinib Hydrochloride
×
Clear all
No trials found.